After disappointing efficacy data and a patient death, Oncternal Therapeutics is discontinuing two trials and looking for strategic alternatives.
The San Diego company said it …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
There are times when a new medical technology is thrust into the public spotlight because it seems like it might solve what we thought was
Edwards Lifesciences confirmed Tuesday that EU officials conducted an unannounced inspection at company premises in Europe last week to investigate antitrust concerns. The Irvine, California-based
As a new class of obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients.